Cognitive phenotypes in Parkinson's disease: A latent profile analysis.


Journal

Neuropsychology
ISSN: 1931-1559
Titre abrégé: Neuropsychology
Pays: United States
ID NLM: 8904467

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 9 7 2021
Statut: ppublish

Résumé

Neurocognitive disorders in Parkinson's disease (PD) are common and heterogeneous. The aim of this study was to use a data-driven method to describe different cognitive phenotypes in PD and to explore anxiety, depression, and motor disturbances across the different cognitive profiles. Latent profile analysis was applied to the neuropsychological performances of 65 patients with idiopathic PD assessed by means of a battery of tests that encompass measures of attention, memory, executive functions, social cognition, language, and visuospatial abilities. A three-cluster model produced the best solution: Cluster A (21.54%) included patients with intact cognition or with a relatively slight cognitive impairment in memory and executive functioning; Cluster B (53.85%) included patients with an intermediate level of cognitive impairment; and Cluster C (24.61%) included patients with the most severe cognitive impairment, with greater deficit compared to Cluster B in executive functioning, and, notably, in tasks with a predominantly posterior cortical basis (naming and visuospatial abilities). The three subgroups did not differ in terms of age, gender, disease duration, motor symptom severity or side of onset, levodopa equivalent daily dose, level of anxiety, or depression; however, patients from Cluster C showed greater impairment than patients from Cluster A in measures of everyday functioning. We presented a qualitative description of three distinct cognitive phenotypes emerging from a sample of 65 PD patients. The three clusters seem to be related to daily functioning but are independent from the stage of disease, motor functioning, anxiety, and depression. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Identifiants

pubmed: 34043394
pii: 2021-48909-010
doi: 10.1037/neu0000737
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-459

Auteurs

Edoardo Barvas (E)

CeRiN, Centro di Riabilitazione Neurocognitiva, CIMeC, Università di Trento.

Giulia Mattavelli (G)

Scuola universitaria superiore, IUSS Pavia.

Francesca Zappini (F)

CeRiN, Centro di Riabilitazione Neurocognitiva, CIMeC, Università di Trento.

Floriana Giardina (F)

Unità Operativa di Neurologia, Ospedale Santa Maria del Carmine.

Donatella Ottaviani (D)

Unità Operativa di Neurologia, Ospedale Santa Maria del Carmine.

Costanza Papagno (C)

CeRiN, Centro di Riabilitazione Neurocognitiva, CIMeC, Università di Trento.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH